SRI-7614

N/A

Report date: 2023/09/27 09:15:15
NME

Base Information

Drug NameSRI-7614
Drug Alias NameSRI-7614
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSouthern Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSouthern Research Institute
Active IndicationsN/A
Inactive IndicationsTuberculosis, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A